Search results for "ddc:"

showing 10 items of 3080 documents

Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with…

2018

Summary Venous thromboembolism (VTE)‐BLEED, a decision tool for predicting major bleeding during chronic anticoagulation for VTE has not yet been validated in practice‐based conditions. We calculated the prognostic indices of VTE‐BLEED for major bleeding after day 30 and day 90, as well as for recurrent VTE and all‐cause mortality, in 4457 patients enrolled in the international, prospective XALIA study. The median at‐risk time was 190 days (interquartile range 106–360). The crude hazard ratio (HR) for major bleeding after day 30 was 2·6 [95% confidence interval (CI) 1·3–5·2] and the treatment‐adjusted HR was 2·3 (95% CI 1·1–4·5) for VTE‐BLEED high (versus low) risk patients: the correspondi…

AdultMalemedicine.medical_specialtyvenous thromboembolismHemorrhage030204 cardiovascular system & hematologyDisease-Free Survival03 medical and health sciencesYoung Adult0302 clinical medicineInterquartile rangePredictive Value of TestsInternal medicinemedicineanticoagulation therapy; bleeding; prediction; rivaroxaban; venous thromboembolism; HematologyHumans030212 general & internal medicinecardiovascular diseasesProspective StudiesAdverse effectrivaroxabanRivaroxabananticoagulation therapybusiness.industryIncidence (epidemiology)Platelets Haemostasis and ThrombosisHazard ratioHematologypredictionBleedMiddle Agedequipment and suppliesbleedingConfidence intervalddc:Survival RateCohortFemalebusinessmedicine.drugResearch Paper
researchProduct

Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) – results from a nationwide cohort in German…

2013

Objective The objective of this article is to evaluate the safety and clinical outcome of rituximab treatment in systemic lupus erythematosus (SLE) patients refractory to standard of care therapy in a real-life setting in Germany. Methods The GRAID registry included patients with different autoimmune diseases who were given off-label treatment with rituximab. Data on safety and clinical response were collected retrospectively. In SLE patients, clinical parameters included tender and swollen joint counts, fatigue, myalgia, general wellbeing, Raynaud’s and the SLEDAI index. Laboratory tests included dsDNA antibody titres, complement factors, hematologic parameters and proteinuria. Finally, th…

AdultMalemyalgiamedicine.medical_specialty610 MedizinCohort StudiesAntibodies Monoclonal Murine-DerivedRheumatologyRefractoryInternal medicineHumansLupus Erythematosus SystemicMedicineIn patientskin and connective tissue diseasesRetrospective Studiesddc:610Proteinuriabusiness.industryOff-Label UseSystemic lupus erythematosus; rituximab; efficacy; safety;Blymphocytes; cohort studiesDiscontinuationCohortPhysical therapyFemaleRituximabmedicine.symptomRituximabbusinessCohort studymedicine.drugLupus
researchProduct

The effect of paired associative stimulation on fatigue resistance

2015

Paired associative stimulation (PAS) is a non-invasive stimulation method developed to induce bidirectional changes in the excitability of the cortical projections to the target muscles. However, very few studies have shown an association between changes in motor evoked potentials (MEP) after PAS and behavioral changes in healthy subjects. In the present study we hypothesized that the functional relevance of PAS can be seen during fatiguing exercise, since there is always a central contribution to the development of fatigue. Transcranial magnetic stimulation was applied over the motor cortex to measure changes in the MEPs of the soleus muscle before and after PAS. Furthermore, fatigue resis…

AdultMalepaired associative stimulationmedicine.medical_treatmentStimulationIsometric exerciseta3112Young AdultPaired associative stimulationFatigue resistancemotor cortextranscranial magnetic stimulationmedicineHumansddc:796Muscle Skeletalta315skin and connective tissue diseasesSoleus muscleNeuronal PlasticityGeneral NeuroscienceHealthy subjectsFatigue; Central fatigue; Motor cortex; Transcranial magnetic stimulation; Paired associative stimulationGeneral MedicineEvoked Potentials Motorcentral fatigueTranscranial magnetic stimulationmedicine.anatomical_structureMuscle FatigueFemalefatiguesense organsPsychologyNeuroscienceMotor cortex
researchProduct

Keeping memory clear and stable--the contribution of human basal ganglia and prefrontal cortex to working memory.

2010

Successful remembering involves both hindering irrelevant information from entering working memory (WM) and actively maintaining relevant information online. Using a voxelwise lesion-behavior brain mapping approach in stroke patients, we observed that lesions of the left basal ganglia render WM susceptible to irrelevant information. Lesions of the right prefrontal cortex on the other hand make it difficult to keep more than a few items in WM. These findings support basal ganglia-prefrontal cortex models of WM whereby the basal ganglia play a gatekeeper role and allow only relevant information to enter prefrontal cortex where this information then is actively maintained in WM.

AdultMalephysiology [Prefrontal Cortex]Interference theoryphysiology [Basal Ganglia]Prefrontal CortexBrain mappingBasal GangliaBasal (phylogenetics)Cortex (anatomy)Basal gangliamedicineHumansphysiopathology [Memory Disorders]complications [Stroke]ddc:610Prefrontal cortexAgedAged 80 and overMemory DisordersBrain Mappingphysiopathology [Stroke]Working memoryGeneral NeurosciencePutamenphysiology [Putamen]Middle AgedMagnetic Resonance Imagingetiology [Memory Disorders]StrokeMemory Short-Termmedicine.anatomical_structurephysiology [Memory Short-Term]pathology [Stroke]Femalediagnosis [Memory Disorders]physiopathology [Putamen]Brief CommunicationsConsumer neurosciencePsychologyNeuroscienceCognitive psychology
researchProduct

Repetition suppression versus enhancement — it's quantity that matters

2013

Upon repetition, certain stimuli induce reduced neural responses (i.e., repetition suppression), whereas others evoke stronger signals (i.e., repetition enhancement). It has been hypothesized that stimulus properties (e.g., visibility) determine the direction of the repetition effect. Here, we show that the very same stimuli can induce both repetition suppression and enhancement, whereby the only determining factor is the number of repetitions. Repeating the same, initially novel low-visible pictures of scenes for up to 5 times enhanced the blood oxygen level-dependent (BOLD) response in scene-selective areas, that is, the parahippocampal place area (PPA) and the transverse occipital sulcus…

AdultMalephysiology [Recognition Psychology]genetic structuresAdolescentCognitive NeuroscienceStimulus (physiology)Brain mappingCellular and Molecular NeuroscienceYoung Adultphysiology [Brain]medicineHumansChromatin structure remodeling (RSC) complexddc:610Bold responseMathematicsCommunicationBrain MappingBlood-oxygen-level dependentbiologymedicine.diagnostic_testbusiness.industryBrainRecognition PsychologyMagnetic Resonance Imagingbiology.proteinTransverse occipital sulcusFemalebusinessFunctional magnetic resonance imagingNeurosciencePhotic Stimulation
researchProduct

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)

2011

Introduction: Evidence from a number of open-label, uncontrolled studies has suggested that rituximab may benefit patients with autoimmune diseases who are refractory to standard-of-care. The objective of this study was to evaluate the safety and clinical outcomes of rituximab in several standard-of-care-refractory autoimmune diseases (within rheumatology, nephrology, dermatology and neurology) other than rheumatoid arthritis or non-Hodgkin's lymphoma in a real-life clinical setting. Methods: Patients who received rituximab having shown an inadequate response to standard-of-care had their safety and clinical outcomes data retrospectively analysed as part of the German Registry of Autoimmune…

AdultNephrologyrituximab; autoimmune diseasesmedicine.medical_specialtyHealth StatusImmunologyDrug ResistanceAutoimmune DiseasesDrug HypersensitivityAntibodies Monoclonal Murine-Derived03 medical and health sciences0302 clinical medicineRheumatologyimmune system diseaseshemic and lymphatic diseasesGermanyInternal medicinemedicineHumansImmunology and Allergyddc:610RegistriesRetrospective Studies030203 arthritis & rheumatologyAutoimmune diseasebusiness.industryRetrospective cohort studymedicine.diseaseRheumatology3. Good healthLymphomaPemphigusTreatment OutcomePatient SatisfactionAntirheumatic AgentsRheumatoid arthritisImmunologyRituximabRituximabbusinessImmunosuppressive Agents030217 neurology & neurosurgeryResearch ArticleFollow-Up Studiesmedicine.drugArthritis Research & Therapy
researchProduct

Impact of the AHI1 gene on the vulnerability to schizophrenia: a case-control association study.

2010

Background: The Abelson helper integration-1 (AHI1) gene is required for both cerebellar and cortical development in humans. While the accelerated evolution of AHI1 in the human lineage indicates a role in cognitive (dys)function, a linkage scan in large pedigrees identified AHI1 as a positional candidate for schizophrenia. To further investigate the contribution of AHI1 to the susceptibility of schizophrenia, we evaluated the effect of AHI1 variation on the vulnerability to psychosis in two samples from Spain and Germany. Methodology/Principal Findings: 29 single-nucleotide polymorphisms (SNPs) located in a genomic region including the AHI1 gene were genotyped in two samples from Spain (28…

AdultPsychosisLinkage disequilibriumAdolescentMental Health/Neuropsychiatric Disorderslcsh:MedicineSingle-nucleotide polymorphismPedigree chartBiologyGenetics and Genomics/Complex TraitsPolymorphism Single NucleotideLinkage DisequilibriumYoung AdultGenotypemedicineHumansGenetic Predisposition to Diseaseddc:610lcsh:ScienceGenetics and Genomics/Genetics of DiseaseAllelesAdaptor Proteins Signal TransducingAgedGeneticsMental Health/Schizophrenia and Other PsychosesMultidisciplinaryHaplotypelcsh:RCase-control studyMiddle AgedSchizophreniemedicine.diseaseAdaptor Proteins Vesicular TransportHaplotypesSchizophreniaCase-Control StudiesSchizophrenialcsh:QResearch ArticlePLoS ONE
researchProduct

Perceptions Underlying Addictive Technology Use Patterns: Insights for Cognitive-Behavioural Therapy

2022

International audience; Cognitive-Behavioural Therapy (CBT) is considered the ‘gold standard’ in the treatment of addictive disorders related to excessive technology use. However, the cognitive components of problematic internet use are not yet well-known. The aim of the present study was to explore the cognitive components, that according to problematic users, can lead to potential internet addiction. A total of 854 European adults completed an online survey using a mixed-methods design. Internet problems and attachment styles were assessed, prevalence rates estimated, correlations, chi-squared automatic interaction detection, and content analysis were performed. Self-reported addictions t…

AdultTechnologyPreoccupied attachment styleInternet addictionHealth Toxicology and Mutagenesis[SDV]Life Sciences [q-bio]educationBehavioursmanopcognitive-behavioural therapy; cognition; behaviours; internet addiction; compulsive internet use; internet use-related addiction; adults; preoccupied attachment style; mixed-methodsArticleSocial Networking03 medical and health sciencesddc:616.890302 clinical medicineCognitionmental disordersCognitive-behavioural therapyHumansAdultsInternetMixed-methodsCognitive Behavioral TherapyPublic Health Environmental and Occupational HealthR030227 psychiatry3. Good healthBehavior Addictive[SDV] Life Sciences [q-bio]Compulsive internet useVideo GamesMedicineInternet use-related addiction030217 neurology & neurosurgery
researchProduct

Intravascular volume therapy in adults guidelines from the association of the scientific medical societies in Germany

2016

No abstract available.

Adultmedicine.medical_specialtyCritical CareHypovolemiaMEDLINEMedizinBlood volumelaw.inventionLactated ringers solution03 medical and health sciences0302 clinical medicineRandomized controlled trial030202 anesthesiologylawGermanymedicineIntravascular volume statusHumansddc:610Intensive care medicineBlood VolumeElective cesarean sectionbusiness.industryCentral venous pressure030208 emergency & critical care medicine3. Good healthAnesthesiology and Pain MedicineFluid Therapybusiness
researchProduct

A53T-Alpha-Synuclein Overexpression Impairs Dopamine Signaling and Striatal Synaptic Plasticity in Old Mice

2010

BACKGROUND: Parkinson's disease (PD), the second most frequent neurodegenerative disorder at old age, can be caused by elevated expression or the A53T missense mutation of the presynaptic protein alpha-synuclein (SNCA). PD is characterized pathologically by the preferential vulnerability of the dopaminergic nigrostriatal projection neurons. METHODOLOGY/PRINCIPAL FINDINGS: Here, we used two mouse lines overexpressing human A53T-SNCA and studied striatal dysfunction in the absence of neurodegeneration to understand early disease mechanisms. To characterize the progression, we employed young adult as well as old mice. Analysis of striatal neurotransmitter content demonstrated that dopamine (DA…

AgingDopaminelcsh:MedicineMicechemistry.chemical_compoundHomer Scaffolding ProteinsReceptor Cannabinoid CB1lcsh:ScienceLong-term depressionNeurotransmitterChromatography High Pressure LiquidIn Situ Hybridization FluorescenceOligonucleotide Array Sequence AnalysisMice KnockoutNeuronal PlasticityMultidisciplinaryReverse Transcriptase Polymerase Chain ReactionDopaminergicNeurodegenerationGenetics and Genomics/Gene ExpressionElectrophysiologyalpha-SynucleinResearch ArticleRadioimmunoprecipitation Assaymedicine.medical_specialtyNeuronal Calcium-Sensor ProteinsHOMER1Substantia nigraNeurotransmissionBiologyNeurological DisordersInternal medicinemedicineAnimalsHumansddc:610Cyclic Nucleotide Phosphodiesterases Type 7Activating Transcription Factor 2lcsh:RNeuropeptidesmedicine.diseaseMolecular biologyCorpus StriatumMice Mutant StrainsEndocrinologyGenetics and Genomics/Disease ModelschemistrySynaptic plasticitylcsh:QCarrier ProteinsPLoS ONE
researchProduct